{"url_path":"/sec/mgtx/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1735438/0001104659-26-060739-index.html","accession_number":"0001104659-26-060739","cik":"0001735438","ticker":"MGTX","issuer_name":"MeiraGTx Holdings plc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1735438/0001104659-26-060739-index.html","primary_entity_key":"0001735438","primary_entity_name":"MeiraGTx Holdings plc"},"word_count":152,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities.\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n​\n\n** **\n\n​\n\n** **\n\n​\n\n** **\n\n​\n\n** **\n\n**Approximate Dollar**\n\n​\n\n** **\n\n​\n\n** **\n\n​\n\n​\n\n** **\n\n**Total Number of Shares**\n\n** **\n\n**Value of Shares that**\n\n​\n\n** **\n\n**Total Number**\n\n** **\n\n**Average**\n\n** **\n\n**Purchased as Part of**\n\n** **\n\n**May Yet Be Purchased**\n\n​\n\n** **\n\n**of Shares**\n\n** **\n\n**Price Paid**\n\n** **\n\n**Publicly Announced Plans**\n\n** **\n\n**Under the Plans or**\n\n**Period:**\n\n​\n\n**Purchased (a)**\n\n** **\n\n**per Share**\n\n** **\n\n**or Programs**\n\n** **\n\n**Programs**\n\n1/1/2026 - 1/31/2026\n\n \n\n2,300,000\n\n \n\n$\n\n7.91\n\n \n\n—\n\n \n\n$\n\n—\n\n2/1/2026 - 2/28/2026\n\n \n\n—\n\n​\n\n$\n\n—\n\n \n\n—\n\n \n\n$\n\n—\n\n3/1/2026 - 3/31/2026\n\n \n\n—\n\n​\n\n$\n\n—\n\n \n\n—\n\n \n\n$\n\n—\n\nTotal\n\n \n\n2,300,000\n\n​\n\n​\n\n​\n\n \n\n—\n\n \n\n​\n\n—\n\n​\n\n(a) Reflects ordinary shares we repurchased from Perceptive Life Sciences Master Fund, Ltd. under a share purchase agreement dated December 31, 2025. The repurchase transaction was completed on January 5, 2026.\n\n​\n\n103\n\n[Table of Contents](#TOC)"}